Literature DB >> 12020332

Ethnic disparities in diabetic complications in an insured population.

Andrew J Karter1, Assiamira Ferrara, Jennifer Y Liu, Howard H Moffet, Lynn M Ackerson, Joe V Selby.   

Abstract

CONTEXT: Higher rates of microvascular complications have been reported for minorities. Disparate access to quality health care is a common explanation for ethnic disparities in diabetic complication rates in the US population. Examining an ethnically diverse population with uniform health care coverage may be useful.
OBJECTIVE: To assess ethnic disparities in the incidence of diabetic complications within a nonprofit prepaid health care organization. DESIGN AND
SETTING: Longitudinal observational study conducted January 1, 1995, through December 31, 1998, at Kaiser Permanente Medical Care Program in northern California. PARTICIPANTS: A total of 62 432 diabetic patients, including Asians (12%), blacks (14%), Latinos (10%), and whites (64%). MAIN OUTCOME MEASURES: Incident myocardial infarction (MI), stroke, congestive heart failure (CHF), and nontraumatic lower extremity amputation (LEA), defined by primary hospitalization discharge diagnosis, procedures, or underlying cause of death; and end-stage renal disease (ESRD), defined as renal insufficiency requiring renal replacement therapy or transplantation for survival or by underlying cause of death.
RESULTS: Patterns of ethnic differences were not consistent across complications and frequently persisted despite adjustment for a wide range of demographic, socioeconomic, behavioral, and clinical factors. Adjusted hazard ratios (relative to that of whites) were 0.56, 0.68, and 0.68 for blacks, Asians, and Latinos, respectively (P<.001), for MI; 0.76 and 0.72 for Asians and Latinos, respectively (P<.01), for stroke; 0.70 and 0.61 for Asians and Latinos, respectively (P<.01), for CHF; 0.40 for Asians (P<.001) for LEA; and 2.03, 1.85, and 1.46 for blacks, Asians, and Latinos, respectively (P<.01), for ESRD. There were no statistically significant black-white differences for stroke, CHF, or LEA and no Latino-white differences for LEA.
CONCLUSIONS: This study confirms previous reports of elevated incidence of ESRD among ethnic minorities, despite uniform medical care coverage, and provides new evidence that rates of other complications are similar or lower relative to those of whites. The persistence of ethnic disparities after adjustment suggests a possible genetic origin, the contribution of unmeasured environmental factors, or a combination of these factors.

Entities:  

Mesh:

Year:  2002        PMID: 12020332     DOI: 10.1001/jama.287.19.2519

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  352 in total

1.  Diabetes connect: African American men's preferences for a community-based diabetes management program.

Authors:  Krysia Crabtree; Nathan Sherrer; Tullia Rushton; Amanda Willig; April Agne; Tanya Shelton; Andrea Cherrington
Journal:  Diabetes Educ       Date:  2014-11-03       Impact factor: 2.140

2.  Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

Authors:  Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

3.  Self-reported neighborhood safety and nonadherence to treatment regimens among patients with type 2 diabetes.

Authors:  John Billimek; Dara H Sorkin
Journal:  J Gen Intern Med       Date:  2011-09-21       Impact factor: 5.128

4.  Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the rhinasthma questionnaire.

Authors:  Hubert Chen; Miriam G Cisternas; Patricia P Katz; Theodore A Omachi; Laura Trupin; Edward H Yelin; John R Balmes; Paul D Blanc
Journal:  Ann Allergy Asthma Immunol       Date:  2011-01-08       Impact factor: 6.347

Review 5.  Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently?

Authors:  Andrew D Paterson; Shelley B Bull
Journal:  J Cardiovasc Transl Res       Date:  2012-06-23       Impact factor: 4.132

6.  Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study.

Authors:  Elbert S Huang; Neda Laiteerapong; Jennifer Y Liu; Priya M John; Howard H Moffet; Andrew J Karter
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

7.  Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO.

Authors:  Connie Mah Trinacty; Alyce S Adams; Stephen B Soumerai; Fang Zhang; James B Meigs; John D Piette; Dennis Ross-Degnan
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

8.  Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Authors:  Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

9.  Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans.

Authors:  Csaba P Kovesdy; Keith C Norris; L Ebony Boulware; Jun L Lu; Jennie Z Ma; Elani Streja; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Circulation       Date:  2015-09-18       Impact factor: 29.690

10.  Depression and risk of hospitalizations for ambulatory care-sensitive conditions in patients with diabetes.

Authors:  Dimitry S Davydow; Wayne J Katon; Elizabeth H B Lin; Paul Ciechanowski; Evette Ludman; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2013-01-17       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.